Who Owns Aldeyra Therapeutics Stock?
NASDAQ: ALDXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 61.54%
- Held by insiders
- 3.60%
- Institutional holders
- 136
- Institutions 61.5%
- Insiders 3.6%
- Public and other 34.9%
Who owns Aldeyra Therapeutics stock?
Institutional investors own about 61.5% of Aldeyra Therapeutics's shares, spread across 136 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 3.60% of ALDX.
The largest institutional holders are Knoll Capital Management, LLC (9.08%), AQR Capital Management, LLC (6.22%) and Kingdon Capital Management LLC (4.40%). Together, the top 10 institutions control 38.0% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their ALDX positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ALDX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Knoll Capital Management, LLC | 5.48M | 9.08% | 0.0% |
| AQR Capital Management, LLC | 3.75M | 6.22% | +32.6% |
| Kingdon Capital Management LLC | 2.65M | 4.40% | +23.2% |
| Vanguard Capital Management LLC | 2.36M | 3.92% | -0.1% |
| Shaw D.E. & Co., Inc. | 1.94M | 3.22% | +38.2% |
| Marshall Wace LLP | 1.51M | 2.50% | +1061.9% |
| 683 Capital Management LLC | 1.45M | 2.40% | -3.3% |
| Jane Street Group, LLC | 1.38M | 2.28% | +41.9% |
| Blackrock Inc. | 1.26M | 2.08% | -66.6% |
| Qube Research & Technologies Ltd | 1.13M | 1.87% | +1196.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ALDX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.78M | 2.96% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 521.51K | 0.86% |
| Vanguard Explorer Fund | 331.51K | 0.55% |
| VANGUARD VARIABLE INSURANCE FUNDS-Small Company Growth Portfolio | 308.15K | 0.51% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 276.80K | 0.46% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 250.28K | 0.41% |
| iShares Trust-iShares Micro-Cap ETF | 186.30K | 0.31% |
| VANGUARD WORLD FUND-Vanguard Health Care Index Fund | 154.61K | 0.26% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Micro Cap Portfolio | 140.33K | 0.23% |
| Invesco Exchange-Traded Fund Trust-Invesco RAFI US 1500 Small-Mid ETF | 105.13K | 0.17% |
Frequently asked questions
Who is the largest shareholder of Aldeyra Therapeutics?
Knoll Capital Management, LLC is the largest institutional shareholder of ALDX, owning 9.08% of shares outstanding (5.48M shares) as of its latest 13F filing.
What percentage of Aldeyra Therapeutics is owned by institutions?
Institutions own about 61.5% of ALDX shares and 63.8% of the public float.
How much of Aldeyra Therapeutics do insiders own?
Insiders, such as officers and directors, own about 3.60% of ALDX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.